Overview
US insurance and employee benefits provider's Q1 adjusted EPS rose 23%, beating analyst expectations
Q1 revenue grew 3% but missed analyst expectations
Adjusted earnings growth driven by higher variable investment income, volume growth and favorable underwriting
Outlook
MetLife did not provide specific guidance for the current qtr or full yr
Result Drivers
VARIABLE INVESTMENT INCOME - Co said higher variable investment income, especially from private equity, contributed to earnings growth
VOLUME GROWTH - Adjusted PFOs, excluding pension risk transfers, increased 10%, with growth in all segments
FAVORABLE UNDERWRITING - Co said favorable underwriting supported earnings growth in Group Benefits
Company press release: ID:nBw22c4gBa
Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q1 Revenue
Miss
$19.07 bln
$19.48 bln (7 Analysts)
Q1 Adjusted EPS
Beat
$2.42
$2.27 (16 Analysts)
Q1 EPS
$1.74
Q1 Adjusted Net Income
$1.59 bln
Q1 Net Income
$1.14 bln
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 13 "strong buy" or "buy", 6 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the life & health insurance peer group is "buy"
Wall Street's median 12-month price target for MetLife Inc is $89.00, about 11.4% above its May 5 closing price of $79.90
The stock recently traded at 8 times the next 12-month earnings vs. a P/E of 8 three months ago
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)